Search - tctmd.com

Displaying 141 - 160 of 3027

Sort: Relevancy | Date

News Daily News

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

L.A. McKeown

November 25, 2024

News Conference News AHA 2024

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

Michael O'Riordan

November 21, 2024

Presentation AHA 2024

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Presenter: Kausik K. Ray

November 17, 2024

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Conference News TCT 2024

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

Yael L. Maxwell

November 01, 2024

Presentation TCT 2024

TCT 856: Evaluating the Diagnostic Validity of Incremental Acetylcholine Doses for Inducing Coronary Artery Spasm in ANOCA

Presenter: Chinmay Khandkar

October 30, 2024

Presentation TCT 2024

TCT 680: Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA): Full Clinical Picture, Risk Factors, and NT-proBNP/Troponin Ratio as a Novel Diagnostic Method

Presenter: Natalia Krajewska

October 30, 2024

Presentation TCT 2024

TCT 681: Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Non-Significant Obstructive Coronary Artery Disease

Presenter: Shoichi Kuramitsu

October 30, 2024

Presentation TCT 2024

TCT 682: Gender Difference in the Outcomes of Patients With Spontaneous Coronary Artery Dissection Presenting With ST-Elevation Myocardial Infarction and Developing Cardiogenic Shock

Presenter: Mohammed Abdelazeem

October 30, 2024

Presentation TCT 2024

TCT 683: Clinical Outcomes in Patients With Spontaneous Coronary Artery Dissection (SCAD) and Concurrent Ventricular Arrhythmias: A Systematic Review and Meta-Analysis?

Presenter: Haseeb Tareen

October 30, 2024

Presentation TCT 2024

TCT 684: Repeat Coronary Angiography in Patients Aged Over 50 Years With Previously Normal/Non-Obstructive Coronary Angiogram: Insights From a Retrospective Single Center Study

Presenter: Rami Abu Fanne

October 30, 2024

Presentation TCT 2024

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

Presenter: TsungYing Tsai

October 30, 2024

Presentation TCT 2024

TCT 256: Outcomes of Complex Native Vessel Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft Surgery

Presenter: Sachin Kumar

October 30, 2024

Presentation TCT 2024

TCT 346: Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: Patient Data Meta-Analysis of Randomized Clinical Trials: Final Results of the ANDROMEDA Study

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

TCT 259: Validating the BCIS-CHIP Score in the Auckland Population

Presenter: Uddaka Wijesinghe

October 30, 2024

Presentation TCT 2024

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Presenter: Woo Jin Ahn

October 30, 2024

Advertisement

FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy

ZODIAC: Decision-Support Tool Doesn’t Sway Lipid-Lowering Treatments in ACS

OptimiZation Of Lipid Lowering Therapies Using A Decision Support System In Patients With Acute Coronary Syndrome (ZODIAC): A Randomized Controlled Trial

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

TCT 856: Evaluating the Diagnostic Validity of Incremental Acetylcholine Doses for Inducing Coronary Artery Spasm in ANOCA

TCT 680: Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA): Full Clinical Picture, Risk Factors, and NT-proBNP/Troponin Ratio as a Novel Diagnostic Method

TCT 681: Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve-Guided Deferral of Revascularization in Non-Significant Obstructive Coronary Artery Disease

TCT 682: Gender Difference in the Outcomes of Patients With Spontaneous Coronary Artery Dissection Presenting With ST-Elevation Myocardial Infarction and Developing Cardiogenic Shock

TCT 683: Clinical Outcomes in Patients With Spontaneous Coronary Artery Dissection (SCAD) and Concurrent Ventricular Arrhythmias: A Systematic Review and Meta-Analysis?

TCT 684: Repeat Coronary Angiography in Patients Aged Over 50 Years With Previously Normal/Non-Obstructive Coronary Angiogram: Insights From a Retrospective Single Center Study

TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype

TCT 256: Outcomes of Complex Native Vessel Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft Surgery

TCT 346: Assessment of Long-Term Clinical Outcomes of De Novo DCB Performance: Patient Data Meta-Analysis of Randomized Clinical Trials: Final Results of the ANDROMEDA Study

TCT 259: Validating the BCIS-CHIP Score in the Auckland Population

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content